# Renal Tubular Acidosis: Type 1 vs 2 vs 4

> What is the difference between type 1, type 2 and type 4 renal tubular acidosis?

Distal, proximal and hyperkalemic RTA compared cell by cell, with the drug causes, urine tests and treatment that separate them on exam day.

Type 1 (distal) renal tubular acidosis is failed hydrogen-ion secretion: urine pH cannot fall below 5.5, potassium runs low and calcium phosphate stones are common. Type 2 (proximal) is a bicarbonate leak, often with Fanconi syndrome, causing hypokalemia but acidic urine once bicarbonate settles. Type 4 is aldosterone deficiency or resistance: hyperkalemia with acidic urine.

## What is the difference between type 1, type 2 and type 4 RTA?

All three share one blood picture, a hyperchloremic, normal anion gap metabolic acidosis with relatively preserved glomerular filtration; they differ in which acid-handling job fails. The proximal tubule reclaims 85-90% of filtered bicarbonate, mostly by sodium-hydrogen exchange; the distal nephron secretes hydrogen ions; and ammonia made from glutamine buffers them so they leave as ammonium. Type 2 breaks the first job, type 1 the second, and type 4 mainly starves the third, because missing aldosterone raises potassium and hyperkalemia suppresses ammonia production.

Type 4 is the most common type in the United States and worldwide, mainly from diabetic kidney disease and urinary obstruction; type 2 is rarer than type 1, and type 3 is vanishingly rare. Potassium and urine pH sort nearly every vignette; related topics sit on the [Nephrology](/topics/nephrology) hub.

## RTA types chart: type 1 vs type 2 vs type 4

Each column's labs follow from its first two rows.

| Feature | Type 1 (distal) | Type 2 (proximal) | Type 4 (hyperkalemic) |
| --- | --- | --- | --- |
| Site of defect | α-intercalated cells of the distal nephron | Proximal tubule | Principal and α-intercalated cells lacking aldosterone signal |
| Mechanism | H⁺ secretion fails, or secreted H⁺ leaks back | Lowered threshold for reclaiming filtered HCO₃⁻ | Low aldosterone effect; high K⁺ suppresses ammoniagenesis |
| Serum K⁺ | Low; usually improves once alkali starts | Low; alkali therapy deepens it | High |
| Urine pH during acidosis | Above 5.5 despite acidemia | Below 5.5 once HCO₃⁻ settles; above 7 while it is near normal | Below 5.5 |
| Serum HCO₃⁻ | Often under 15 mEq/L, can fall below 10 | Typically 12-20 mEq/L | Mildly low, usually over 17 mEq/L |
| Urine anion gap | Positive | Variable: negative expected at steady state, positive during bicarbonaturia | Positive |
| Stones and nephrocalcinosis | Calcium phosphate stones, nephrocalcinosis | Not typical | Not typical |
| Bone disease | Rickets, growth failure, osteomalacia | Hypophosphatemic rickets or osteomalacia | Not typical |
| Associated syndrome | Sjögren syndrome; inherited forms with hearing loss | Fanconi syndrome | Hyporeninemic hypoaldosteronism of diabetes |
| Classic causes | Sjögren, lupus, rheumatoid arthritis; amphotericin B, lithium; medullary sponge kidney | Myeloma light chains, cystinosis; acetazolamide, topiramate, tenofovir, ifosfamide | Diabetic nephropathy; ACE inhibitors, ARBs, NSAIDs, heparin, trimethoprim, K⁺-sparing diuretics; Addison disease |
| Treatment | Alkali 1-2 mEq/kg/day; potassium citrate if K⁺ is low or stones form | Alkali over 10 mEq/kg/day plus K⁺; thiazide; phosphate and vitamin D | Low-K⁺ diet, diuretic, stop culprit drugs; fludrocortisone if aldosterone-deficient |

Two rarer forms sit outside the main columns.

| Footnote form | Defect | How it differs | Classic setting |
| --- | --- | --- | --- |
| Type 3 (mixed) | Carbonic anhydrase II deficiency: proximal leak plus distal defect | Features of types 1 and 2; NIDDK calls the label rarely used | Osteopetrosis, cerebral calcification, intellectual disability ("marble brain disease") |
| Hyperkalemic distal RTA | Distal sodium reabsorption falls, cutting H⁺ and K⁺ secretion | High K⁺ like type 4, urine pH above 5.5 like type 1 | Chronic urinary obstruction, sickle cell disease |

## RTA mnemonic: pump, leak, hormone

One frame carries the chart: type 1 is a broken pump, type 2 is a leak, and type 4 is a missing hormone signal. The labs run in the same order: potassium is low, low, high; urine pH at steady state is high, low, low; and stones with nephrocalcinosis point to the broken pump. The [visual RTA chart](/blog/2026-06-03-visual-hack-renal-tubular-acidosis-types-1-2-4-made-easy) draws the same split along the nephron.

## Inside the tubule: what fails in each type

Step 1 asks for mechanisms, so tie each type to its failing cell.

**Type 1: the α-intercalated cell.** Carbonic anhydrase inside the cell turns CO₂ and water into H⁺ and HCO₃⁻. Apical H⁺-ATPase and H⁺/K⁺-ATPase pump the H⁺ into the urine, and the basolateral AE1 exchanger returns the HCO₃⁻ to the blood in exchange for chloride. Inherited forms include AE1 variants (SLC4A1, no hearing loss) and proton-pump subunit variants with sensorineural hearing loss, earliest with ATP6V1B1 (infancy) and later with ATP6V0A4; acquired distal RTA in adults is mostly autoimmune. Amphotericin B works differently: the pump runs, but a leaky membrane lets secreted H⁺ diffuse back. Failed H⁺/K⁺-ATPase exchange also wastes potassium. Stones follow from three changes at once: more urinary calcium (acidosis pulls it from bone), less urinary citrate (the tubule reclaims citrate as a buffer) and a persistently alkaline urine in which calcium phosphate crystallizes.

**Type 2: the proximal tubule.** An apical sodium-hydrogen exchanger, working with carbonic anhydrase, reclaims filtered bicarbonate, and a basolateral sodium-bicarbonate cotransporter (encoded by SLC4A4) delivers it to the blood. In type 2 this machinery saturates early. Bicarbonate filtered above the patient's reset threshold escapes, so the urine is alkaline while plasma bicarbonate is near normal; losses stop once plasma bicarbonate has fallen to the threshold, and the healthy distal nephron then acidifies normally. Alkali lifts the filtered load back over the threshold, so much of it is lost, and the extra sodium and bicarbonate reaching the distal nephron increase potassium secretion. Acetazolamide and topiramate reproduce the pattern by inhibiting carbonic anhydrase.

**Type 4: the collecting duct without aldosterone.** In principal cells, aldosterone promotes apical sodium (ENaC) and potassium channels, so sodium is reabsorbed and potassium secreted; in α-intercalated cells it stimulates the H⁺-ATPase, so acid secretion depends on it too. Lose the hormone (diabetic hyporeninemic hypoaldosteronism, Addison disease, ACE inhibitors, heparin) or block its receptor (spironolactone, eplerenone), and potassium climbs. Hyperkalemia then compounds the problem by suppressing ammoniagenesis in the proximal tubule, so the collecting duct runs short of the NH₃ buffer that would trap secreted H⁺ as NH₄⁺. The urine can still reach a pH below 5.5, because so little NH₃ is there to buffer the H⁺ that is secreted, yet total acid excretion is low. A 2018 mouse study in JASN showed the sequence: hyperkalemia lowered proximal ammonia-generating enzymes and collecting-duct ammonia transport, and lowering potassium with hydrochlorothiazide corrected the acidosis.

## Fanconi syndrome behind proximal RTA

Fanconi syndrome is generalized proximal tubular failure, and proximal RTA is only one of its parts. Glucose appears in the urine despite a normal plasma glucose, along with amino acids, phosphate, bicarbonate, uric acid and low-molecular-weight proteins, so serum phosphate, uric acid and potassium fall. Phosphate wasting, with reduced vitamin D activation, drives rickets in children and osteomalacia in adults; polyuria and dehydration are common, and children fail to grow.

- **Inherited:** nephropathic cystinosis is the most common inherited cause (about 1 in 100,000 to 200,000 births); others are Wilson disease, galactosemia, hereditary fructose intolerance, tyrosinemia, Lowe syndrome and Dent disease.
- **Acquired:** light-chain proximal tubulopathy in multiple myeloma, lead or cadmium, and drugs including tenofovir, ifosfamide, cisplatin, gentamicin and valproic acid.

Cysteamine slows cystinosis; otherwise treatment means removing the cause and replacing alkali, potassium, phosphate and vitamin D. The myeloma angle is drilled in this [multiple myeloma question breakdown](/blog/2026-06-17-q-bank-breakdown-multiple-myeloma-why-every-answer-choice-matters).

## Drug causes of RTA, matched to type

Each drug below points to one segment; current FDA labels state most effects directly.

| Drug | Usual pattern | Mechanism or label point |
| --- | --- | --- |
| Amphotericin B (deoxycholate) | Type 1 | Secreted H⁺ back-diffuses; label lists RTA, hypokalemia, nephrocalcinosis; liposomal form causes less hypokalemia |
| Lithium | Type 1 | Label: RTA with hyperchloremic acidosis, besides nephrogenic diabetes insipidus |
| Ifosfamide | Type 2 (Fanconi); also listed for type 1 | Boxed warning includes nephrotoxicity; label lists Fanconi syndrome and osteomalacia |
| Tenofovir disoproxil fumarate | Type 2 (Fanconi) | Proximal tubulopathy with severe hypophosphatemia; osteomalacia with bone pain |
| Acetazolamide, topiramate | Type 2 pattern | Carbonic anhydrase inhibition wastes bicarbonate; topiramate also lowers urinary citrate and raises urine pH, adding stones |
| ACE inhibitors, ARBs | Type 4 | Less angiotensin II, so less aldosterone secretion |
| NSAIDs | Type 4 | Label attributes hyperkalemia to hyporeninemic hypoaldosteronism |
| Heparin, including low-molecular-weight heparin | Type 4 | Suppresses adrenal aldosterone secretion; usually reversible |
| Spironolactone, eplerenone | Type 4 | Block aldosterone at the mineralocorticoid receptor |
| Amiloride, triamterene | Type 4 | Block distal sodium reabsorption, so potassium is retained |
| Trimethoprim, pentamidine | Type 4 | Raise potassium; trimethoprim most at high Pneumocystis doses |
| Cyclosporine, tacrolimus | Type 4 | Labeled hyperkalemia, with hyperchloremic acidosis on the cyclosporine label |

## How to work up a suspected RTA

Suspect RTA in any unexplained normal anion gap metabolic acidosis with near-normal kidney function, once the [step-by-step acid-base method](/blog/how-to-approach-acid-base-questions-usmle) has confirmed a normal, albumin-corrected gap.

1. **Urine anion gap**, (urine Na⁺ + urine K⁺) − urine Cl⁻. Ammonium is the main unmeasured urinary cation in acidosis, so a clearly negative value (roughly −30 to −50 mEq/L) signals appropriate renal acid excretion: a gut source or, on sparse data, type 2 at steady state. A positive gap means too little ammonium (types 1 and 4) or bicarbonate escaping into the urine.
2. **Urine pH while acidemic.** Above 5.5 means distal acidification has failed (type 1 or hyperkalemic distal RTA); below 5.5 fits type 2 at steady state or type 4. Urease-producing infection or chronic diarrhea (extra ammonia) can also raise urine pH.
3. **Serum potassium.** High points to type 4, or to hyperkalemic distal RTA when urine pH is above 5.5; low points to type 1 or type 2.
4. **The company it keeps.** Glucosuria with a normal glucose, low phosphate or uric acid, or acetazolamide or topiramate means type 2; stones, nephrocalcinosis or Sjögren syndrome mean type 1; diabetes or a culprit drug means type 4.

Classic exam teaching reads the urine anion gap as an ammonium meter, but a 2021 JASN review argues that at steady state it mostly mirrors dietary sodium, potassium and chloride, shifts with urine pH because phosphate's charge changes, and misleads during non-steady states such as potassium chloride repletion. Its authors recommend measuring urine ammonium directly, and urinary ketones also distort the gap.

Two confirmatory tests matter mostly as exam concepts. In the ammonium chloride load (100 mg/kg by mouth), plasma bicarbonate should fall to 21 mmol/L or less; a urine pH still above 5.5 confirms type 1, and furosemide plus fludrocortisone is an alternative stimulus. In the bicarbonate infusion test, plasma bicarbonate is raised toward normal: in type 2, urine pH climbs above 7.5 and fractional bicarbonate excretion exceeds 15%, against a normal value under 5%.

## Treatment of each RTA type

Alkali corrects types 1 and 2, but type 2 needs a far larger dose (above 10 versus 1-2 mEq/kg/day), and type 4 is treated mainly by lowering potassium.

| Type | Mainstay | Dose or target | Pitfall |
| --- | --- | --- | --- |
| Type 1 | Sodium bicarbonate or citrate; potassium citrate if K⁺ is low or stones form | About 1-2 mEq/kg/day in adults; more per kilogram in children | Alkali halts nephrocalcinosis but does not reverse it |
| Type 2 | Large alkali doses with potassium salts; a thiazide | Above 10 mEq/kg/day, often 10-15 | Bicarbonate diuresis raises urinary K⁺ loss |
| Type 2 with Fanconi syndrome | Add phosphate and vitamin D; cysteamine for cystinosis | Normal serum phosphate, healed bone disease | The tubular defect itself persists |
| Type 4 | Lower potassium and remove the cause | Dietary K⁺ 40-60 mEq/day; loop or thiazide diuretic; potassium binder if needed | Potassium citrate is contraindicated in hyperkalemia |
| Type 4 with aldosterone deficiency | Fludrocortisone | 0.05-0.2 mg/day, often more in hyporeninemic hypoaldosteronism | Sodium retention can worsen hypertension, edema and heart failure |

Potassium citrate (Urocit-K) carries an FDA indication for RTA with calcium stones. Fludrocortisone is labeled only for adrenal insufficiency and salt-losing congenital adrenal hyperplasia, so in hyporeninemic hypoaldosteronism it is off-label; in [Addison disease](/blog/2026-06-09-everything-you-need-to-know-about-addison-disease-for-step-1) it is part of replacement with a glucocorticoid. Current potassium binders include patiromer and sodium zirconium cyclosilicate.

> **10-second RTA read:** Normal anion gap with a clearly negative urine anion gap -> diarrhea, unless Fanconi clues suggest type 2. Otherwise check potassium. High K⁺ with urine pH below 5.5 -> type 4; above 5.5 -> hyperkalemic distal RTA. Low K⁺ with urine pH above 5.5 -> type 1, often with stones or Sjögren. Low K⁺ with urine pH below 5.5 -> type 2, often with glucosuria, low phosphate or acetazolamide.

## How USMLE tests RTA: patterns and traps

The USMLE content outline names renal tubular acidosis and Fanconi syndrome among renal metabolic and regulatory disorders, and Step 1 gives the respiratory and renal/urinary systems 11-15% of its items combined.

- **Child with polyuria, growth failure, rickets and glucosuria with a normal glucose:** Fanconi syndrome, classically nephropathic cystinosis.
- **Diabetic with CKD, potassium near 6, bicarbonate near 19, urine pH 5.0 after starting lisinopril or trimethoprim-sulfamethoxazole:** type 4.
- **Topiramate user with a normal-gap acidosis and a kidney stone:** carbonic anhydrase inhibition.
- **Trap: calling every hyperkalemic RTA type 4.** Urine pH above 5.5 means hyperkalemic distal RTA.
- **Trap: potassium citrate for type 4.** High potassium contraindicates it.
- **Trap: expecting bicarbonate to fix type 2 easily.** Much of it spills, dragging potassium out.
- **Trap: a glomerular sediment.** Red cell casts or heavy proteinuria belong to [nephrotic vs nephritic syndrome](/blog/nephrotic-vs-nephritic-syndrome-usmle), not RTA.

## Worked vignette: bone pain after years of HIV therapy

A 46-year-old man with HIV infection has had 4 months of aching pain in his hips and feet and new proximal muscle weakness. His regimen has included tenofovir disoproxil fumarate for 9 years. Serum: sodium 138, potassium 3.0, chloride 112 and bicarbonate 17 mEq/L; glucose 94 mg/dL; phosphate 1.7 mg/dL; uric acid 2.0 mg/dL; creatinine 1.3 mg/dL. Urinalysis shows 2+ glucose and a pH of 5.3. Which of the following best explains his acid-base disorder?

- **A.** Impaired H⁺ secretion by α-intercalated cells
- **B.** Reduced proximal tubular reabsorption of filtered bicarbonate
- **C.** Deficient aldosterone action in the collecting duct
- **D.** Gastrointestinal loss of bicarbonate
- **E.** Accumulation of an unmeasured organic anion

**Answer: B.** The anion gap is 138 − (112 + 17) = 9, a normal-gap acidosis. Glucosuria with a normal serum glucose, low phosphate and low uric acid mean Fanconi syndrome, which the tenofovir disoproxil fumarate label lists, along with osteomalacia that presents as bone pain. A urine pH of 5.3 fits type 2 at steady state: plasma bicarbonate has fallen to the lowered threshold, so the distal nephron acidifies normally. **A** (type 1) would keep urine pH above 5.5 and would not explain glucosuria or phosphate wasting. **C** (type 4) raises potassium; his is 3.0. **D** causes neither glucosuria nor phosphate wasting. **E** would widen the anion gap.

**Next step:** switch from tenofovir disoproxil fumarate to another antiretroviral, as the HIV guideline advises, and replace alkali, potassium and phosphate.

## Sources

- StatPearls (NCBI Bookshelf): [Renal tubular acidosis](https://www.ncbi.nlm.nih.gov/books/NBK519044/), [Fanconi syndrome](https://www.ncbi.nlm.nih.gov/books/NBK534872/)
- GeneReviews (NCBI Bookshelf): [Hereditary distal renal tubular acidosis](https://www.ncbi.nlm.nih.gov/books/NBK547595/)
- NIDDK: [Renal tubular acidosis](https://www.niddk.nih.gov/health-information/kidney-disease/renal-tubular-acidosis)
- Uribarri J, Oh MS: [The urine anion gap: common misconceptions, JASN 2021](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8259693/)
- PubMed: [Harris 2018, hyperkalemic acidosis](https://pubmed.ncbi.nlm.nih.gov/29483157/), [Kashoor 2019, proximal RTA](https://pubmed.ncbi.nlm.nih.gov/31474092/), [Palmer 2021, RTA review](https://pubmed.ncbi.nlm.nih.gov/33367987/), [Giglio 2021, distal RTA](https://pubmed.ncbi.nlm.nih.gov/33770395/)
- USMLE: [content outline](https://www.usmle.org/sites/default/files/2022-01/USMLE_Content_Outline_0.pdf), [Step 1 content specifications](https://www.usmle.org/exam-resources/step-1-materials/step-1-content-outline-and-specifications)
- Clinical Info HIV.gov: [adverse effects of antiretroviral agents](https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/adverse-effects-antiretroviral-agents)
- FDA labels on DailyMed, checked October 2026.

Make the potassium and urine pH split automatic before test day: [Test yourself on RTA with StepGenie adaptive questions](https://dashboard.stepgenie.app/sign-up).

## Frequently asked questions

### What is an easy mnemonic for RTA types 1, 2 and 4?

Think pump, leak, hormone. Type 1 is a broken distal acid pump, type 2 is a proximal bicarbonate leak, and type 4 is missing or blocked aldosterone. The labs follow in the same order: potassium is low, low, then high, and urine pH at steady state is high, low, then low. Calcium phosphate stones and nephrocalcinosis point to type 1. If potassium is high but urine pH stays above 5.5, think hyperkalemic distal RTA rather than type 4.

### What causes type 4 renal tubular acidosis?

Type 4 renal tubular acidosis comes from too little aldosterone or a kidney that cannot respond to it. The leading adult cause is diabetic kidney disease with hyporeninemic hypoaldosteronism, and urinary obstruction is another. Drug causes include ACE inhibitors, ARBs, NSAIDs, heparin, spironolactone, eplerenone, amiloride, trimethoprim, pentamidine, cyclosporine and tacrolimus. Addison disease, congenital adrenal hyperplasia and pseudohypoaldosteronism also cause it. The resulting hyperkalemia suppresses ammonia production, which produces a mild acidosis.

### Which drugs cause renal tubular acidosis?

Each drug points to a type. Amphotericin B and lithium cause distal (type 1) RTA, and ifosfamide can cause distal RTA or Fanconi syndrome. Tenofovir disoproxil fumarate causes proximal tubulopathy with Fanconi syndrome, while acetazolamide and topiramate inhibit carbonic anhydrase and waste bicarbonate in a proximal pattern. Type 4 follows drugs that lower aldosterone, block its effect or reduce potassium excretion: ACE inhibitors, ARBs, heparin, NSAIDs, trimethoprim, pentamidine, potassium-sparing diuretics and calcineurin inhibitors.

### What is type 3 renal tubular acidosis?

Type 3 renal tubular acidosis is a vanishingly rare mixed form that combines the proximal bicarbonate leak of type 2 with the distal acidification defect of type 1. Its inherited form comes from carbonic anhydrase II deficiency, which also causes osteopetrosis, cerebral calcification and intellectual disability, a picture nicknamed marble brain disease. NIDDK notes that the type 3 label is rarely used now, which is why most charts show only types 1, 2 and 4.

### Can distal renal tubular acidosis cause high potassium?

Yes. Distal RTA is usually hypokalemic, but a hyperkalemic form occurs when distal sodium reabsorption fails, as in chronic urinary obstruction or sickle cell disease, so potassium and hydrogen-ion secretion fall together. It mimics type 4 because potassium is high, but urine pH stays above 5.5 during acidosis, whereas type 4 acidifies the urine below 5.5. That urine pH is the deciding clue when a vignette shows a hyperkalemic normal anion gap acidosis.

---

Canonical page: [Renal Tubular Acidosis: Type 1 vs 2 vs 4](https://www.stepgenie.app/blog/renal-tubular-acidosis-types-usmle)
Topic hub: [Nephrology](https://www.stepgenie.app/topics/nephrology)